Evidence map›Paper›PMID 34025983›Full record

ArticleClinical and translational allergy2021

Non-specific lipid-transfer proteins: Allergen structure and function, cross-reactivity, sensitization, and epidemiology.

Isabel J Skypala, Ricardo Asero, Domingo Barber, Lorenzo Cecchi, Arazeli Diaz Perales, Karin Hoffmann-Sommergruber, Elide A Pastorello, Ines Swoboda, Joan Bartra, Didier G Ebo and 10 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Clinical and translational allergy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06558526 (Analysis of the Clinical Efficacy and Immunomodulatory Effect of Pectin in LTP Allergic Patients Through a Placebo-controlled Intervention Study and Long-term Follow-up), which is not on this map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06558526 narecruitingnot on this mapstarted 2025, after this paper: background citation

Analysis of the Clinical Efficacy and Immunomodulatory Effect of Pectin in LTP Allergic Patients Through a Placebo-controlled Intervention Study and Long-term Follow-up

TypeinterventionalSponsorFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludRan2025 to 2026Enrolled62ConditionsFood AllergyArmsApple pectin (DE 57%), Placebo
3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Evolution of IgE sensitization profiles toThe World Allergy Organization journal · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. A Human Monoclonal Antibody Displays Promiscuous Binding to Multiple Type 1 nsLTP Allergens.Journal of investigational allergology & clinical immunology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. IgE-mediated lipid transfer protein allergy in children.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2025
    Review
  18. Article
  19. The role of neutrophils in allergic disease.Clinical and experimental immunology · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 17 institutions in 8 countries.

Isabel J SkypalaDepartment of Allergy & Clinical Immunology Royal Brompton & Harefield NHS Foundation Trust Imperial College London UK.ORCID https://orcid.org/0000-0003-3629-4293
Ricardo AseroAmbulatorio di Allergologia Clinica San Carlo Milan Italy.ORCID https://orcid.org/0000-0002-8277-1700
Domingo BarberIMMA School of Medicine Universidad San Pablo CEU CEU Universities Madrid Spain.ORCID https://orcid.org/0000-0002-5488-5700
Lorenzo CecchiSOS Allergy and Clinical Immunology USL Toscana Centro Prato Italy.ORCID https://orcid.org/0000-0002-0658-2449
Arazeli Diaz PeralesDepartamento de Biotecnología-Biología Vegetal Centro de Biotecnología y Genómica de Plantas (CBGP, UPM-INIA) Universidad Politécnica de Madrid Madrid Spain.ORCID https://orcid.org/0000-0002-1093-3627
Karin Hoffmann-SommergruberDepartment of Pathophysiology and Allergy Research Medical University of Vienna Austria.ORCID https://orcid.org/0000-0002-8830-058X
Elide A PastorelloUnit of Allergology and Immunology ASST Grande Ospedale Metropolitano Niguarda University of Milan Milan Italy.ORCID https://orcid.org/0000-0002-3753-1783
Ines SwobodaBiotechnology Section FH Campus Wien University of Applied Sciences Vienna Austria.ORCID https://orcid.org/0000-0002-9164-1721
Joan BartraHospital Clinic de Barcelona IDIBAPS Universitat de Barcelona ARADyAL Barcelona Spain.ORCID https://orcid.org/0000-0001-7767-4730
Didier G EboDepartment of Immunology, Allergology, Rheumatology and Infla-Med Centre of Excellence Faculty of Medicine and Health Sciences University of Antwerp and Antwerp University Hospital Ghent Belgium.ORCID https://orcid.org/0000-0003-0672-7529
Margaretha A FaberDepartment of Immunology, Allergology, Rheumatology and Infla-Med Centre of Excellence Faculty of Medicine and Health Sciences University of Antwerp and Antwerp University Hospital Ghent Belgium.ORCID https://orcid.org/0000-0002-1277-5052
Montserrat Fernández-RivasDepartment of Allergy Hospital Clínico San Carlos Universidad Complutense de Madrid IdISSC, ARADyAL Madrid Spain.ORCID https://orcid.org/0000-0003-1748-2328
Francesca GomezAllergy Unit IBIMA- Hospital Regional Universitario de Malaga Malaga and Spanish Network for Allergy - RETICS de Asma, Reacciones adversas y Alérgicas (ARADyAL) Madrid Spain.ORCID https://orcid.org/0000-0003-1607-6686
Anastasios P KonstantinopoulosAllergy Department 2nd Paediatric Clinic University of Athens Athens Greece.ORCID https://orcid.org/0000-0002-7060-653X
Olga LuengoAllergy Unit, Internal Medicine Department Vall d'Hebron University Hospital Universitat Autònoma de Barcelona ARADyAL Barcelona Spain.ORCID https://orcid.org/0000-0002-8905-2776
Ronald van ReeDepartment of Experimental Immunology and Department of Otorhinolaryngology Amsterdam University Medical Centers location AMC Amsterdam The Netherlands.
Enrico ScalaExperimental Allergy Unit Istituto Dermopatico Dell'immacolata IRCCS FLMM Rome Italy.ORCID https://orcid.org/0000-0002-9391-9168
Stephen J TillPeter Gorer Department of Immunobiology King's College London London UK.ORCID https://orcid.org/0000-0003-4518-3093
European Academy of Allergy
Clinical Immunology (EAACI) Task Force: Non‐specific Lipid Transfer Protein Allergy Across Europe
University of Antwerp · BEAmsterdam University Medical Centers · NLAzienda Usl Toscana Centro · ITCentre for Plant Biotechnology and Genomics · ESHochschule Campus Wien · ATHospital Clínic de Barcelona · ESHospital Regional Universitario de Málaga · ESIstituto Dermopatico dell'Immacolata · ITKing's College London · GBMedical University of Vienna · ATNational and Kapodistrian University of Athens · GROspedale San Carlo · ITRoyal Brompton & Harefield NHS Foundation Trust · GBUniversidad Complutense de Madrid · ESUniversidad San Pablo CEU · ESUniversitat Autònoma de Barcelona · ESUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiscovered and described 40 years ago, non-specific lipid transfer proteins (nsLTP) are present in many plant species and play an important role protecting plants from stressors such as heat or drought. In the last 20 years, sensitization to nsLTP and consequent reactions to plant foods has become an increasing concern.

aimThe aim of this paper is to review the evidence for the structure and function of nsLTP allergens, and cross-reactivity, sensitization, and epidemiology of nsLTP allergy. MATERIALS AND

methodsA Task Force, supported by the European Academy of Allergy & Clinical Immunology (EAACI), reviewed current evidence and provide a signpost for future research. The search terms for this paper were "Non-specific Lipid Transfer Proteins", "LTP syndrome", "Pru p 3", "plant food allergy", "pollen-food syndrome".

resultsMost nsLTP allergens have a highly conserved structure stabilised by 4-disulphide bridges. Studies on the peach nsLTP, Pru p 3, demonstrate that nsLTPs are very cross-reactive, with the four major IgE epitopes of Pru p 3 being shared by nsLTP from other botanically related fruits. These nsLTP allergens are to varying degrees resistant to heat and digestion, and sensitization may occur through the oral, inhaled or cutaneous routes. In some populations, Pru p 3 is the primary and sole sensitizing allergen, but many are poly-sensitised both to botanically un-related nsLTP in foods, and non-food sources of nsLTP such as Cannabis sativa, Platanus acerifolia, (plane tree), Ambrosia artemisiifolia (ragweed) and Artemisia vulgaris (mugwort). Initially, nsLTP sensitization appeared to be limited to Mediterranean countries, however more recent studies suggest clinically relevant sensitization occurs in North Atlantic regions and also countries in Northern Europe, with nsLTP sensitisation profiles being broadly similar. DISCUSSION: These robust allergens have the potential to sensitize and provoke symptoms to a large number of plant foods, including those which are raw, cooked or processed. It is unknown why some sensitized individuals develop clinical symptoms to foods whereas others do not, or indeed what other allergens besides Pru p 3 may be primary sensitising allergens. It is clear that these allergens are also relevant in non-Mediterranean populations and there needs to be more recognition of this.

conclusionNon-specific LTP allergens, present in a wide variety of plant foods and pollens, are structurally robust and so may be present in both raw and cooked foods. More studies are needed to understand routes of sensitization and the world-wide prevalence of clinical symptoms associated with sensitization to these complex allergens.

Indexed as

allergyepidemiologyfoodlipid transfer proteinLTPsensitization

Identifiers

PMID34025983
PMCPMC8129635
OpenAlexW3162707885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.